Clinical Trial Update: Clinical Outcomes With Ceftolozane-tazobactam for MDR Pseudomonas Infections

View source ↗

Summary

The update describes clinical outcomes with ceftolozane-tazobactam for multidrug-resistant Pseudomonas infections from a clinical trial, though the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudomonas Aeruginosa Infections
• Pseudomonas Infections

Drugs mentioned

• Zerbaxa (ceftolozane-tazobactam)

Snippet

Sponsor: Temple University | Conditions: Pseudomonas Infections, Pseudomonas Aeruginosa | Status: UNKNOWN